Professor, Internal Medicine, University of Utah School of Medicine

Cardiology

Dale G. Renlund is an expert in the field of Cardiology. He went to medical school at University of Utah School of Medicine. Dale Renlund has written publications. He has 42 publications published with PubMed. The lastest paper is: 'Genome-wide significance and replication of the chromosome 12p11.22 locus near the PTHLH gene for peripartum cardiomyopathy.'

Publications

---

• Genome-wide significance and replication of the chromosome 12p11.22 locus near the PTHLH gene for peripartum Cardiomyopathy.
• Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human Heart.
• Risk factors predictive of right ventricular Failure after left ventricular assist device implantation.
• Effect of ABO-incompatible listing on infant Heart transplant waitlist outcomes: analysis of the United Network for Organ Sharing (UNOS) database.
• Utility of virtual crossmatch in sensitized patients awaiting Heart transplantation.
• Cardiovascular mortality among Heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection.
• Prior human leukocyte antigen-allosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitization.
• Exceptional mortality prediction by risk scores from common laboratory tests.
• Superior predictive ability for death of a basic metabolic profile risk score.
• Outcome of noncardiac surgery in patients with ventricular assist devices.
• Time-dependent changes in B-type natriuretic peptide after Heart transplantation: correlation with allograft rejection and function.
• A clinical correlation study of severity of antibody-mediated rejection and cardiovascular mortality in Heart transplantation.
• Relation of Heart failure hospitalization to exposure to fine particulate air pollution.
• Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
• Incremental survival benefit with adherence to standardized Heart failure core measures: a performance evaluation study of 2958 patients.
• Early screening for antibody-mediated rejection in Heart transplant recipients.
• Validation of the Seattle Heart Failure Model in a community-based Heart failure population and enhancement by adding B-type natriuretic peptide.
• Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: the impact of leukofiltered cellular blood product transfusions.
• The intricacies of Heart failure.
• Effect of reversible pulmonary hypertension on outcomes after Heart transplantation.
• Ischemic Heart disease events triggered by short-term exposure to fine particulate air pollution.
• When the failing, end-stage Heart is not end-stage.
• Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death.
• Impact of repetitive episodes of antibody-mediated or cellular rejection on cardiovascular mortality in cardiac transplant recipients: defining rejection patterns.
• Heart failure epidemic boiling to the surface.
• Relation of serum total cholesterol, C-reactive protein levels, and statin therapy to survival in Heart failure.
• Effect of mechanical circulatory support on outcomes after Heart transplantation.
• Tricuspid valve replacement after cardiac transplantation.
• The paradox of obesity in patients with Heart failure.
• Bridging the resource gap in Heart failure expertise and management: the underacknowledged role of nurse specialists.
• Improved long-term survival associated with stent deployment during percutaneous coronary interventions: results from a registry of 3399 patients.
• Do statins increase the risk of idiopathic polyneuropathy?
• Early failure of a tricuspid valve replacement with a mitral valve homograft in a Heart transplant recipient.
• Improvements in 1-year cardiovascular clinical outcomes associated with a hospital-based discharge medication program.
• Building a bridge to Heart transplantation.
• A common variant of the AMPD1 gene predicts improved survival in patients with ischemic left ventricular dysfunction.
• Consensus statement: Palliative and supportive care in advanced Heart failure.
• Left ventricular assist device malfunction: a systematic approach to diagnosis.
• Sensitivity of rhythm disturbance detection by community hospital telemetry.
• Comparison of the beta blocker bucindolol in younger versus older patients with Heart failure.
• Becker muscular dystrophy-related Cardiomyopathy: a favorable response to medical therapy.

Schools

---

• University of Utah

• Johns Hopkins Hospital

Procedures Preformed

---

• Cardiac Imaging

Conditions Treated

---

• Cardiomegaly
• Cardiomyopathy
• Congestive Heart Failure
• Hyperlipidemia
• View All

Doctors Specialties

---

• Cardiology

Accepted Insurances

---

Education

---

• Johns Hopkins University
• University of Utah School of Medicine

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Sherman G. Sorensen, MD This Doctor is OpenDoctor Recommended.
	Dr. Robert W. Mackie, MD
	Dr. Jerry D. Walker Jr., MD This Doctor is OpenDoctor Recommended.
	Dr. Anwar Tandar, MD This Doctor is OpenDoctor Recommended.
	Dr. Michael J. Preece, MD
	Dr. Rashmee U. Shah, MD This Doctor is OpenDoctor Recommended.
	Dr. Michael F. Sheets, MD This Doctor is OpenDoctor Recommended.
	Dr. Matthew A. Movsesian, MD
	Dr. Travis S. Wall, MD This Doctor is OpenDoctor Recommended.
	Dr. Brent D. Wilson, MD This Doctor is OpenDoctor Recommended.
	Dr. Nassir F. Marrouche, MD This Doctor is OpenDoctor Recommended.
	Dr. Roger L. Borchardt, MD This Doctor is OpenDoctor Recommended.
	Dr. Peyman Nejatbakhsh Azadani, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog